UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.462

Sortiert nach

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

British journal of cancer, 2010-01, Vol.102 (2), p.301-315

2010

Volltextzugriff (PDF)

Le bérotralstat réduit le taux de crises d’angio-œdème héréditaire (AOH) chez les patients adolescents : analyse en sous-groupe de l’étude APeX-S

La revue de medecine interne, 2021-12, Vol.42, p.A406-A406

2021

Volltextzugriff (PDF)

Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis

Annals of oncology, 2015-04, Vol.26 (4), p.688-695

2015

Volltextzugriff (PDF)

La prévention à long terme des crises d’AOH par le béroltralstat est bien tolérée et efficace : résultats de l’étude APeX-S

La revue de medecine interne, 2023-06, Vol.44, p.A119-A120

2023

Volltextzugriff (PDF)

Reply to letter to the editor ‘Primum non nocere’ by Templeton and Šeruga

Annals of oncology, 2015-10, Vol.26 (10), p.2198-2199

2015

Volltextzugriff (PDF)

P045 BEROTRALSTAT DEMONSTRATES LOW HEREDITARY ANGIOEDEMA (HAE) ATTACK RATES IN PATIENTS SWITCHING FROM INJECTABLE PROPHYLAXIS

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S26-S27

2021

Volltextzugriff (PDF)

D005 CONSISTENTLY LOW HEREDITARY ANGIOEDEMA (HAE) ATTACK RATES OBSERVED IN US PATIENTS TREATED WITH BEROTRALSTAT

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S14

2021

Volltextzugriff (PDF)

P048 IMPROVED PATIENT SATISFACTION WITH BEROTRALSTAT IN PATIENTS SWITCHING FROM INJECTABLE HEREDITARY ANGIOEDEMA (HAE) PROPHYLACTIC TREATMENTS

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S27

2021

Volltextzugriff (PDF)

BEROTRALSTAT REDUCED ATTACK RATES COMPARED TO BASELINE IN PATIENTS WITH HEREDITARY ANGIOEDEMA IN APEX-S

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S32-S32

2023

Volltextzugriff (PDF)

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

European journal of cancer (1990), 1993, Vol.29 (3), p.319-324

1993

Volltextzugriff (PDF)

Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline

Supportive care in cancer, 2004-04, Vol.12 (4), p.253-262

2004

Volltextzugriff (PDF)

P053 SUSTAINED REDUCTION IN HEREDITARY ANGIOEDEMA ATTACK RATES FOLLOWING SWITCH TO BEROTRALSTAT: SUBGROUP ANALYSIS FROM APEX-2

Annals of allergy, asthma, & immunology, 2021-11, Vol.127 (5), p.S29

2021

Volltextzugriff (PDF)

Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease

American journal of epidemiology, 1991-01, Vol.133 (1), p.32-37

1991

Volltextzugriff (PDF)

Enantioselective Alkenylation and Phenylation Catalyzed by a Chiral CuF Complex

Journal of the American Chemical Society, 2005-03, Vol.127 (12), p.4138-4139

2005

Volltextzugriff (PDF)

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

JNCI : Journal of the National Cancer Institute, 2002-08, Vol.94 (16), p.1211-1220

2002

Volltextzugriff (PDF)

Variations in the Use of Medication for the Treatment of Childhood Asthma in the Michigan Medicaid Population, 1980 to 1986

Chest, 1993-12, Vol.104 (6), p.1727-1732

1993

Volltextzugriff (PDF)

MA02.05 A Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S359-S359

2018

Volltextzugriff (PDF)

Long-term safety and efficacy of darbepoetin alfa in subjects with stage IV NSCLC receiving multi-cycle chemotherapy

Annals of oncology, 2017-04, Vol.28, p.ii48

2017

Volltextzugriff (PDF)

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

Annals of internal medicine, 1994-10, Vol.121 (7), p.492

1994

Volltextzugriff (PDF)

Mandibular reconstructive surgery in a patient with median cleft of the lower lip and mandible

International journal of oral and maxillofacial surgery, 2002-10, Vol.31 (5), p.549-552

2002

Volltextzugriff (PDF)

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis

Leukemia & lymphoma, 2012-11, Vol.53 (11), p.2151-2158

2012

Volltextzugriff (PDF)

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

Biologics, 2018-01, Vol.12, p.171-182

2018

Volltextzugriff (PDF)

The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy

Annals of oncology, 1997-11, Vol.8 (11), p.1117-1124

1997

Volltextzugriff (PDF)

Stent-in-stent self-expandable metallic stent placement under direct cholangioscopy with the use of short double-balloon endoscope for a Roux-en-Y case

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy, 2019-11, Vol.4 (11), p.522-524

2019

Volltextzugriff (PDF)

1 – 25 von 1.462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.312)
Mit Volltextzugriff
(1.304)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(926)
Life Sciences & Biomedicine
(707)
Humans
(519)
Male
(350)
Female
(339)
Biological And Medical Sciences
(245)
Middle Aged
(207)
Animals
(193)
Medical Sciences
(188)
Aged
(187)
Adult
(173)
Surgery
(147)
Physical Sciences
(143)
Technology
(121)
Physics
(118)
Neurosciences & Neurology
(105)
Cardiovascular System & Cardiology
(103)
Cardiac & Cardiovascular Systems
(86)
Oncology
(86)
Aged, 80 And Over
(79)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

Le bérotralstat réduit le taux de crises d’angio-œdème héréditaire (AOH) chez les patients adolescents : analyse en sous-groupe de l’étude APeX-S

Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysis

La prévention à long terme des crises d’AOH par le béroltralstat est bien tolérée et efficace : résultats de l’étude APeX-S

Reply to letter to the editor ‘Primum non nocere’ by Templeton and Šeruga

P045 BEROTRALSTAT DEMONSTRATES LOW HEREDITARY ANGIOEDEMA (HAE) ATTACK RATES IN PATIENTS SWITCHING FROM INJECTABLE PROPHYLAXIS

D005 CONSISTENTLY LOW HEREDITARY ANGIOEDEMA (HAE) ATTACK RATES OBSERVED IN US PATIENTS TREATED WITH BEROTRALSTAT

P048 IMPROVED PATIENT SATISFACTION WITH BEROTRALSTAT IN PATIENTS SWITCHING FROM INJECTABLE HEREDITARY ANGIOEDEMA (HAE) PROPHYLACTIC TREATMENTS

BEROTRALSTAT REDUCED ATTACK RATES COMPARED TO BASELINE IN PATIENTS WITH HEREDITARY ANGIOEDEMA IN APEX-S

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

Darbepoetin alfa in lung cancer patients on chemotherapy: a retrospective comparison of outcomes in patients with mild versus moderate-to-severe anaemia at baseline

P053 SUSTAINED REDUCTION IN HEREDITARY ANGIOEDEMA ATTACK RATES FOLLOWING SWITCH TO BEROTRALSTAT: SUBGROUP ANALYSIS FROM APEX-2

Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease

Enantioselective Alkenylation and Phenylation Catalyzed by a Chiral CuF Complex

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

Genetic instability, CpG island methylator phenotype and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum

Variations in the Use of Medication for the Treatment of Childhood Asthma in the Michigan Medicaid Population, 1980 to 1986

MA02.05 A Double-Blind, Randomized, Placebo-Controlled Phase 3 Noninferiority Study of Darbepoetin Alfa for Anemia in Advanced NSCLC

Long-term safety and efficacy of darbepoetin alfa in subjects with stage IV NSCLC receiving multi-cycle chemotherapy

Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial

Mandibular reconstructive surgery in a patient with median cleft of the lower lip and mandible

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis

Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results

The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy

Stent-in-stent self-expandable metallic stent placement under direct cholangioscopy with the use of short double-balloon endoscope for a Roux-en-Y case

Suchergebnisse filtern